Selected research
Market Structure
Global Tablet Pharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tablet Pharmaceutical Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tablet Pharmaceutical Excipients include Merck, Lubrizol, Roquette, Protheragen-ING, Meggle-Pharma, Kerry Group, IFF Pharma Solutions, Gattefossé and DFE Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Tablet Pharmaceutical Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tablet Pharmaceutical Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tablet Pharmaceutical Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tablet Pharmaceutical Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.
Tablet Pharmaceutical Excipients Segment by Company
Merck
Lubrizol
Roquette
Protheragen-ING
Meggle-Pharma
Kerry Group
IFF Pharma Solutions
Gattefossé
DFE Pharma
Colorcon
BASF
Abitec
Tablet Pharmaceutical Excipients Segment by Type
Disintegrants
Lubricants
Binders
Colorants
Others
Tablet Pharmaceutical Excipients Segment by Application
Tablets for Oral Use
Tablets for External Use
Tablet Pharmaceutical Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tablet Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet Pharmaceutical Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tablet Pharmaceutical Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tablet Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tablet Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tablet Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Disintegrants
- Lubricants
- Binders
- Colorants
- Others
Applications
- Tablets for Oral Use
- Tablets for External Use
Companies covered
- Merck
- Lubrizol
- Roquette
- Protheragen-ING
- Meggle-Pharma
- Kerry Group
- IFF Pharma Solutions
- Gattefossé
- DFE Pharma
- Colorcon
- BASF
- Abitec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Tablet Pharmaceutical Excipients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Tablet Pharmaceutical Excipients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Tablet Pharmaceutical Excipients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Tablet Pharmaceutical Excipients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Tablet Pharmaceutical Excipients Market Dynamics
- 2.1 Tablet Pharmaceutical Excipients Industry Trends
- 2.2 Tablet Pharmaceutical Excipients Industry Drivers
- 2.3 Tablet Pharmaceutical Excipients Industry Opportunities and Challenges
- 2.4 Tablet Pharmaceutical Excipients Industry Restraints
3 Tablet Pharmaceutical Excipients Market by Manufacturers
- 3.1 Global Tablet Pharmaceutical Excipients Revenue by Manufacturers (2021-2026)
- 3.2 Global Tablet Pharmaceutical Excipients Sales by Manufacturers (2021-2026)
- 3.3 Global Tablet Pharmaceutical Excipients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Tablet Pharmaceutical Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tablet Pharmaceutical Excipients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tablet Pharmaceutical Excipients Manufacturers, Product Type & Application
- 3.7 Global Tablet Pharmaceutical Excipients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tablet Pharmaceutical Excipients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tablet Pharmaceutical Excipients Players Market Share by Revenue in 2025
- 3.8.3 2025 Tablet Pharmaceutical Excipients Tier 1, Tier 2, and Tier 3
4 Tablet Pharmaceutical Excipients Market by Type
- 4.1 Tablet Pharmaceutical Excipients Type Introduction
- 4.1.1 Disintegrants
- 4.1.2 Lubricants
- 4.1.3 Binders
- 4.1.4 Colorants
- 4.1.5 Others
- 4.2 Global Tablet Pharmaceutical Excipients Sales by Type
- 4.2.1 Global Tablet Pharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tablet Pharmaceutical Excipients Sales by Type (2021-2032)
- 4.2.3 Global Tablet Pharmaceutical Excipients Sales Market Share by Type (2021-2032)
- 4.3 Global Tablet Pharmaceutical Excipients Revenue by Type
- 4.3.1 Global Tablet Pharmaceutical Excipients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tablet Pharmaceutical Excipients Revenue by Type (2021-2032)
- 4.3.3 Global Tablet Pharmaceutical Excipients Revenue Market Share by Type (2021-2032)
5 Tablet Pharmaceutical Excipients Market by Application
- 5.1 Tablet Pharmaceutical Excipients Application Introduction
- 5.1.1 Tablets for Oral Use
- 5.1.2 Tablets for External Use
- 5.2 Global Tablet Pharmaceutical Excipients Sales by Application
- 5.2.1 Global Tablet Pharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tablet Pharmaceutical Excipients Sales by Application (2021-2032)
- 5.2.3 Global Tablet Pharmaceutical Excipients Sales Market Share by Application (2021-2032)
- 5.3 Global Tablet Pharmaceutical Excipients Revenue by Application
- 5.3.1 Global Tablet Pharmaceutical Excipients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tablet Pharmaceutical Excipients Revenue by Application (2021-2032)
- 5.3.3 Global Tablet Pharmaceutical Excipients Revenue Market Share by Application (2021-2032)
6 Global Tablet Pharmaceutical Excipients Sales by Region
- 6.1 Global Tablet Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tablet Pharmaceutical Excipients Sales by Region (2021-2032)
- 6.2.1 Global Tablet Pharmaceutical Excipients Sales by Region (2021-2026)
- 6.2.2 Global Tablet Pharmaceutical Excipients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Tablet Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tablet Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tablet Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Tablet Pharmaceutical Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Tablet Pharmaceutical Excipients Revenue by Region
- 7.1 Global Tablet Pharmaceutical Excipients Revenue by Region
- 7.1.1 Global Tablet Pharmaceutical Excipients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Tablet Pharmaceutical Excipients Revenue by Region (2021-2026)
- 7.1.3 Global Tablet Pharmaceutical Excipients Revenue by Region (2027-2032)
- 7.1.4 Global Tablet Pharmaceutical Excipients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Tablet Pharmaceutical Excipients Revenue (2021-2032)
- 7.2.2 North America Tablet Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Tablet Pharmaceutical Excipients Revenue (2021-2032)
- 7.3.2 Europe Tablet Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Tablet Pharmaceutical Excipients Revenue (2021-2032)
- 7.4.2 Asia-Pacific Tablet Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Tablet Pharmaceutical Excipients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Tablet Pharmaceutical Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Tablet Pharmaceutical Excipients Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Lubrizol
- 8.2.1 Lubrizol Company Information
- 8.2.2 Lubrizol Business Overview
- 8.2.3 Lubrizol Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Lubrizol Tablet Pharmaceutical Excipients Product Portfolio
- 8.2.5 Lubrizol Recent Developments
- 8.3 Roquette
- 8.3.1 Roquette Company Information
- 8.3.2 Roquette Business Overview
- 8.3.3 Roquette Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Roquette Tablet Pharmaceutical Excipients Product Portfolio
- 8.3.5 Roquette Recent Developments
- 8.4 Protheragen-ING
- 8.4.1 Protheragen-ING Company Information
- 8.4.2 Protheragen-ING Business Overview
- 8.4.3 Protheragen-ING Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Protheragen-ING Tablet Pharmaceutical Excipients Product Portfolio
- 8.4.5 Protheragen-ING Recent Developments
- 8.5 Meggle-Pharma
- 8.5.1 Meggle-Pharma Company Information
- 8.5.2 Meggle-Pharma Business Overview
- 8.5.3 Meggle-Pharma Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Meggle-Pharma Tablet Pharmaceutical Excipients Product Portfolio
- 8.5.5 Meggle-Pharma Recent Developments
- 8.6 Kerry Group
- 8.6.1 Kerry Group Company Information
- 8.6.2 Kerry Group Business Overview
- 8.6.3 Kerry Group Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kerry Group Tablet Pharmaceutical Excipients Product Portfolio
- 8.6.5 Kerry Group Recent Developments
- 8.7 IFF Pharma Solutions
- 8.7.1 IFF Pharma Solutions Company Information
- 8.7.2 IFF Pharma Solutions Business Overview
- 8.7.3 IFF Pharma Solutions Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 IFF Pharma Solutions Tablet Pharmaceutical Excipients Product Portfolio
- 8.7.5 IFF Pharma Solutions Recent Developments
- 8.8 Gattefossé
- 8.8.1 Gattefossé Company Information
- 8.8.2 Gattefossé Business Overview
- 8.8.3 Gattefossé Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Gattefossé Tablet Pharmaceutical Excipients Product Portfolio
- 8.8.5 Gattefossé Recent Developments
- 8.9 DFE Pharma
- 8.9.1 DFE Pharma Company Information
- 8.9.2 DFE Pharma Business Overview
- 8.9.3 DFE Pharma Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 DFE Pharma Tablet Pharmaceutical Excipients Product Portfolio
- 8.9.5 DFE Pharma Recent Developments
- 8.10 Colorcon
- 8.10.1 Colorcon Company Information
- 8.10.2 Colorcon Business Overview
- 8.10.3 Colorcon Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Colorcon Tablet Pharmaceutical Excipients Product Portfolio
- 8.10.5 Colorcon Recent Developments
- 8.11 BASF
- 8.11.1 BASF Company Information
- 8.11.2 BASF Business Overview
- 8.11.3 BASF Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 BASF Tablet Pharmaceutical Excipients Product Portfolio
- 8.11.5 BASF Recent Developments
- 8.12 Abitec
- 8.12.1 Abitec Company Information
- 8.12.2 Abitec Business Overview
- 8.12.3 Abitec Tablet Pharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Abitec Tablet Pharmaceutical Excipients Product Portfolio
- 8.12.5 Abitec Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Tablet Pharmaceutical Excipients Value Chain Analysis
- 9.1.1 Tablet Pharmaceutical Excipients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tablet Pharmaceutical Excipients Production Mode & Process
- 9.2 Tablet Pharmaceutical Excipients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tablet Pharmaceutical Excipients Distributors
- 9.2.3 Tablet Pharmaceutical Excipients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst